|
Volumn 15, Issue 1, 2002, Pages 1-6
|
Salt intake and hypertension therapy
a a a a |
Author keywords
Clinical trial; Drug therapy; Hypertension; Salt intake
|
Indexed keywords
ADRENERGIC RECEPTOR STIMULATING AGENT;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
ANGIOTENSIN ANTAGONIST;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM;
CALCIUM CHANNEL BLOCKING AGENT;
CAPTOPRIL;
CHLORTALIDONE;
CLONIDINE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
FUROSEMIDE;
HYDROCHLOROTHIAZIDE;
ISRADIPINE;
MAGNESIUM;
METOPROLOL;
OXPRENOLOL;
POTASSIUM;
ADRENERGIC SYSTEM;
ANTIHYPERTENSIVE ACTIVITY;
ANTIHYPERTENSIVE THERAPY;
BLOOD PRESSURE;
BLOOD PRESSURE REGULATION;
BORDERLINE HYPERTENSION;
CALCIUM INTAKE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
DIETARY INTAKE;
DRUG MECHANISM;
ELDERLY CARE;
HEREDITY;
HIGH RISK POPULATION;
HUMAN;
HYPERTENSION;
INDUSTRIALIZATION;
KIDNEY FAILURE;
NONHUMAN;
OBESITY;
POTASSIUM INTAKE;
PRACTICE GUIDELINE;
RACE DIFFERENCE;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
REVIEW;
SALT INTAKE;
SODIUM RESTRICTION;
WEIGHT REDUCTION;
BLOOD PRESSURE;
CALCIUM CHANNEL BLOCKERS;
CAPTOPRIL;
DIURETICS;
HUMANS;
HYPERTENSION;
RENIN-ANGIOTENSIN SYSTEM;
RISK FACTORS;
SODIUM, DIETARY;
WEIGHT LOSS;
|
EID: 0036126167
PISSN: 11218428
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (24)
|
References (35)
|